C. Malstrom et S. James, INHIBITION OF MURINE SPLENIC AND MUCOSAL LYMPHOCYTE FUNCTION BY ENTERIC BACTERIAL PRODUCTS, Infection and immunity, 66(7), 1998, pp. 3120-3127
Previously we shelved that lysates of enteropathogenic Escherichia col
i (EPEC) inhibit lymphokine production by mitogen-activated human peri
pheral blood and lamina propria mononuclear cells. The aims of the pre
sent study were to determine whether EPEC-inhibitory factors have simi
lar effects on murine lymphoid populations in order to further delinea
te the mechanisms of alteration of cytokine production. Preexposure to
EPEC lysates inhibited mitogen-stimulated interleukin-2 (IL-2), IL-4,
and gamma interferon (IFN-gamma) production by murine spleen cells, b
ut IL-10 production was increased. The inhibition,vas not due to incre
ased apoptosis and was not blocked by neutralizating antibodies agains
t IL-10 or transforming growth factor beta (TGF-beta), EPEC lysates al
so inhibited mitogen-stimulated IL-2 and IFN-gamma production by CD11b
depleted spleen cells, IL-2 and IL-4 production by intraepithelial an
d Peyer's patch lymphocytes, IL-2 production by the human T-cell line
Jurkat, and antigen-stimulated IL-2 production by murine spleen cells.
Lysates obtained from Shiga-like toxin-producing E, coli, E, coli RDE
C-1, Citrobacter rodentium, and an EPEC espB insertion mutant all inhi
bited IL-2 and IL-4 production by mitogen-stimulated lymphoid cells. I
n conclusion, lysates of EPEC and related bacteria directly inhibit cy
tokine production by lymphoid cells from multiple sites by a mechanism
that does not increase apoptosis or result from secondary effects of
IL-10 or TGF-beta.